Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CD7-H522b | Human | Human CD27 / TNFRSF7 Protein, His Tag (MALS Verified) | ![]() |
![]() ![]() |
![]() ![]() |
CD7-M5252 | Mouse | Mouse CD27 / TNFRSF7 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H5257 | Human | Human CD27 / TNFRSF7 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
CD7-C5259 | Cynomolgus / Rhesus macaque | Cynomolgus / Rhesus macaque CD27 / TNFRSF7 Protein, Mouse IgG2a Fc Tag, low endotoxin | ![]() |
![]() ![]() |
![]() ![]() |
TN7-H82F6 | Human | Biotinylated Human CD27 / TNFRSF7 Protein, Fc,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
CD7-H5254 | Human | Human CD27 / TNFRSF7 Protein, Fc Tag (HPLC verified) | ![]() |
![]() ![]() ![]() ![]() |
![]() ![]() |
Flow Cytometry assay shows that Human CD27, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. CD7-H5257) can bind to Raji cells Surface Human CD70. The concentration of CD27 used is 10 μg/mL (Routinely tested).
Immobilized Mouse CD27, Mouse IgG2a Fc Tag (Cat. No. CD7-M5252) at 2 μg/mL (100 μL/well) can bind Biotinylated Mouse CD70, His Tag, Avi Tag with a linear range of 1-16 ng/mL (QC tested).
The purity of Human CD27, His Tag (Cat. No. CD7-H522b) was more than 85% and the molecular weight of this protein is around 38-48 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
MK-5890 | MK-5890 | Phase Ⅱ | Merck Sharp & Dohme | Non small cell lung cancer (NSCLC) | Details |
LOR-S03 | CDX-527; LOR-A04; LOR-S01; LOR-S03 | Phase Ⅰ | Celldex | Cancer | Details |
Anti-CD27 monoclonal antibody (Aduro Biotech) | BION-1402 | Phase Ⅰ | Aduro BioTech, Merck Sharp & Dohme | Solid tumours | Details |
Varlilumab | CDX-1127 | Phase Ⅱ | Celldex, Cascadian Therapeutics, University of Virginia | Solid tumours, Non-Hodgkin's lymphoma (NHL), Glioblastoma, Melanoma | Details |
This web search service is supported by Google Inc.